HBOT Conversations:

Join us for interviews with researchers, practitioners, industry experts, and patients to share their stories, successes, and expertise relative to hyperbaric oxygen therapy

Subscribe. Join the discussion. Share the hope.

 

 

 

Listen to or Watch the HBOT Conversations Podcast

Listen to the HBOT Converstations podcast by downloading it from your favorite podcasting platform or scroll down and watch an episode here on the HBOT News website:

Watch the HBOT Conversations Podcast

Laurie Anderson – Healing COVID with HBOT (Part 3)

Laurie Anderson – Healing COVID with HBOT (Part 3)

Laurie Anderson – Healing COVID with HBOT (Part 2)

Laurie Anderson – Healing COVID with HBOT (Part 2)

Laurie Anderson – Healing COVID with HBOT (Part 1)

Laurie Anderson – Healing COVID with HBOT (Part 1)

Tom Fox (Part 2)

Tom Fox (Part 2)

Tom Fox (Part 1)

Tom Fox (Part 1)

Elena Schertz & Tom Fox (Part 5)

Elena Schertz & Tom Fox (Part 5)

Elena Schertz & Tom Fox (Part 4)

Elena Schertz & Tom Fox (Part 4)

Elena Schertz & Tom Fox (Part 3)

Elena Schertz & Tom Fox (Part 3)

Elena Schertz & Tom Fox (Part 2)

Elena Schertz & Tom Fox (Part 2)

Elena Schertz & Tom Fox (Part 1)

Elena Schertz & Tom Fox (Part 1)

Dr. Jay Stevens  – Optimizing Health & Longevity

Dr. Jay Stevens – Optimizing Health & Longevity

Evan Fernandez – Warriors on the Water

Evan Fernandez – Warriors on the Water

Dr. Jay Stevens  – Head Injuries

Dr. Jay Stevens – Head Injuries

Jim Hooker – HBOT for Vets (Part 2)

Jim Hooker – HBOT for Vets (Part 2)

Jim Hooker – HBOT for Vets (Part 1)

Jim Hooker – HBOT for Vets (Part 1)

Dr. Hemal Mehta & Vibrant Health University

Dr. Hemal Mehta & Vibrant Health University

Dr. Jay Stevens  – Sports-Related Injuries & Performance Enhancement

Dr. Jay Stevens – Sports-Related Injuries & Performance Enhancement

Ernie Harrison: Veteran with PTSD & TBI

Ernie Harrison: Veteran with PTSD & TBI

Dr. Hemal Mehta & Regenerative Medicine

Dr. Hemal Mehta & Regenerative Medicine

Dr. Hemal Mehta & Fasting (Part 2)

Dr. Hemal Mehta & Fasting (Part 2)

Dr. Hemal Mehta & Fasting (Part 1)

Dr. Hemal Mehta & Fasting (Part 1)

Dr. Jay Stevens – “Learn The Right Fast”

Dr. Jay Stevens – “Learn The Right Fast”

Dr. Peter Canaday (Part 2)

Dr. Peter Canaday (Part 2)

Dr. Peter Canaday (Part 1)

Dr. Peter Canaday (Part 1)

Dr. Paul Harch & Viral / Bacterial Infections

Dr. Paul Harch & Viral / Bacterial Infections

Dr. Paul Harch & 8,101 Genes

Dr. Paul Harch & 8,101 Genes

Dr. Paul Harch & Autism

Dr. Paul Harch & Autism

Dr. Paul Harch & Strokes

Dr. Paul Harch & Strokes

Dr. Paul Harch & Birth Injuries/ Cerebral Palsy

Dr. Paul Harch & Birth Injuries/ Cerebral Palsy

Dr. Paul Harch & The Science Behind the Practice

Dr. Paul Harch & The Science Behind the Practice

Dr. Paul Harch & TBI

Dr. Paul Harch & TBI

Dr. Paul Harch & Thermal Burns

Dr. Paul Harch & Thermal Burns

Dr. Paul Harch & Inflammation

Dr. Paul Harch & Inflammation

Robert Beckman & TreatNow.org

Robert Beckman & TreatNow.org

Elena Schertz & Extivita RTP

Elena Schertz & Extivita RTP

Subscribe Now, It’s Free !

Name(Required)

Recent HBOT News

Clinical Trial – Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma

Standard treatment for glioblastomas includes radiation and chemotherapy with a drug called
temozolomide (Temodar); however, glioblastomas frequently develop resistance to standard
treatment and recur or progress. Glioblastomas are known to have decreased levels of oxygen
compared to normal tissues. There is evidence that these lower oxygen levels in glioblastomas
may contribute to their ability to resist treatment effects of radiation and chemotherapy. In
this study we will look to increase the oxygen concentration within the glioblastoma by
adding hyperbaric treatments (the experimental part of this study) to standard treatment with
radiation and temozolomide in order to see whether increasing the oxygen concentration within
the tumor increases the tumor-killing ability of standard radiation and chemotherapy.

In addition, the investigators are interested to evaluate the effect of this treatment
protocol on a person’s quality of life and level of stress, and, therefore, the investigators
will ask subjects to complete several brief questionnaires while they are on-study.